Resources

JORNAY PM provides all-day ADHD symptom control
upon awakening, through the afternoon, and into the evening1-3

Michael

Teenager Diagnosed With ADHD

Treatment challenge: Michael’s ADHD treatment doesn’t last through his afternoon and evening activities, so he’s having difficulty following his coach’s instructions and struggling to complete homework.

Michael’s ADHD Treatment

Amanda

Adult Diagnosed
With ADHD

Treatment challenge: Amanda’s current ADHD treatment wears off in the late afternoon. She’s tried a short-acting booster, but often gets busy and forgets to take it.

Amanda’s ADHD Treatment
How can JORNAY PM help your patients?
INDICATION

JORNAY PM (methylphenidate HCl extended-release capsules) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.

IMPORTANT SAFETY INFORMATION

BOXED WARNING: ABUSE, MISUSE, AND ADDICTION

JORNAY PM has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including JORNAY PM, can result in overdose and death, and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.

Before prescribing JORNAY PM, assess each patient’s risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout JORNAY PM treatment, reassess each patient’s risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse and addiction.

Please see Important Safety Information and Full Prescribing Information, including Boxed Warning.
References